title: New standards in hypertension and cardiovascular risk management: focus on telmisartan.
abstract: Blockade of the renin-angiotensin system is an important approach in managing high blood pressure, and has increasingly been shown to affect cardiovascular disease processes mediated by angiotensin II throughout the cardiovascular and renal continua. Telmisartan is an angiotensin II receptor blocker (ARB) displaying unique pharmacologic properties, including a longer half life than any other ARB, that result in large and sustained reductions of blood pressure. In patients with mild-to-moderate hypertension, telmisartan has proved superior to other antihypertensive agents (valsartan, losartan, ramipril, perindopril, and atenolol) in controlling blood pressure particularly towards the end of the dosing interval. There is also clinical evidence that telmisartan reduces left ventricular hypertrophy, reduces arterial stiffness and the recurrence of atrial fibrillation, and confers renoprotection. The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial (ONTARGET) study has demonstrated that telmisartan has similar cardiovascular protective effects to ramipril in a large, high-risk patient population but was better tolerated. The powerful and sustained blood pressure control apparent in clinical trials, together with cardiovascular protection and tolerability demonstrated in ONTARGET means that telmisartan may be a preferred option for patients with hypertension.
authors.affiliation: Department of Cardiology, San Gennaro Hospital, Naples, Italy. domenicogalzerano@libero.it
authors.forename: Domenico
authors.initials: D
authors.lastname: Galzerano
authors.forename: Cristina
authors.initials: C
authors.lastname: Capogrosso
authors.forename: Sara
authors.initials: S
authors.lastname: Di Michele
authors.forename: Antonio
authors.initials: A
authors.lastname: Galzerano
authors.forename: Paola
authors.initials: P
authors.lastname: Paparello
authors.forename: Diana
authors.initials: D
authors.lastname: Lama
authors.forename: Carlo
authors.initials: C
authors.lastname: Gaudio
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D047228:Angiotensin II Type 1 Receptor Blockers / Q000494:pharmacology / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000494:pharmacology / Q000627:therapeutic use*; D001565:Benzoates / Q000494:pharmacology / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000188:drug therapy; D002319:Cardiovascular System / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D017257:Ramipril / Q000627:therapeutic use; D012307:Risk Factors; D000077333:Telmisartan
chemical_list: D000319:Adrenergic beta-Antagonists; D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D001562:Benzimidazoles; D001565:Benzoates; D002121:Calcium Channel Blockers; D017257:Ramipril; D000077333:Telmisartan
references.citation: J Physiol. 2001 Feb 1;530(Pt 3):541-50
references.pmid: 11158283
references.citation: J Hum Hypertens. 2004 Jan;18(1):53-9
references.pmid: 14688811
references.citation: Blood Press Suppl. 2008 Jun;1:32-40
references.pmid: 18705533
references.citation: Lancet. 2000 Feb 19;355(9204):637-45
references.pmid: 10696996
references.citation: J Hum Hypertens. 2006 Mar;20(3):177-85
references.pmid: 16306998
references.citation: Stroke. 1999 Nov;30(11):2391-8; discussion 2398-9
references.pmid: 10548676
references.citation: Stroke. 1989 Apr;20(4):473-6
references.pmid: 2648651
references.citation: Drugs Exp Clin Res. 2003;29(2):75-80
references.pmid: 12951837
references.citation: Pharmacogenomics J. 2005;5(1):14-20
references.pmid: 15505642
references.citation: Semin Nephrol. 2004 Mar;24(2):147-57
references.pmid: 15017527
references.citation: FEBS Lett. 2005 Aug 15;579(20):4265-70
references.pmid: 16051229
references.citation: J Hum Hypertens. 1999 Oct;13(10):657-64
references.pmid: 10516734
references.citation: Metabolism. 2006 Sep;55(9):1159-64
references.pmid: 16919533
references.citation: J Hum Hypertens. 2002 Dec;16(12):865-73
references.pmid: 12522468
references.citation: Int J Tissue React. 2003;25(2):51-5
references.pmid: 14518593
references.citation: Eur Heart J. 1992 Sep;13 Suppl D:82-8
references.pmid: 1396865
references.citation: J Renin Angiotensin Aldosterone Syst. 2001 Dec;2(4):246-54
references.pmid: 11881131
references.citation: J Hypertens. 2005 Nov;23(11):2055-61
references.pmid: 16208149
references.citation: J Renin Angiotensin Aldosterone Syst. 2006 Dec;7(4):243-6
references.pmid: 17318795
references.citation: Am J Hypertens. 2005 Dec;18(12 Pt 1):1563-9
references.pmid: 16364826
references.citation: J Cardiovasc Pharmacol. 2001 Nov;38(5):672-85
references.pmid: 11602814
references.citation: Diabetes Res Clin Pract. 2006 Feb;71(2):210-9
references.pmid: 16112244
references.citation: Blood Press Monit. 2007 Jun;12(3):141-7
references.pmid: 17496463
references.citation: N Engl J Med. 2008 Sep 18;359(12):1225-37
references.pmid: 18753639
references.citation: J Am Coll Cardiol. 2005 Mar 1;45(5):712-9
references.pmid: 15734615
references.citation: Diabetes Care. 2007 Jun;30(6):1577-8
references.pmid: 17389334
references.citation: N Engl J Med. 2004 Nov 4;351(19):1952-61
references.pmid: 15516696
references.citation: J Clin Hypertens (Greenwich). 2006 Sep;8(9):626-33
references.pmid: 16957424
references.citation: Clin Ther. 2002 Feb;24(2):302-16
references.pmid: 11911560
references.citation: Diabetes Care. 2005 Mar;28(3):757-8
references.pmid: 15735228
references.citation: Diabetes Care. 2004 Apr;27(4):1015
references.pmid: 15047668
references.citation: Diabetes Care. 2007 Jun;30(6):1351-6
references.pmid: 17337492
references.citation: Cerebrovasc Dis. 2007;23(5-6):368-80
references.pmid: 17337887
references.citation: J Renin Angiotensin Aldosterone Syst. 2003 Dec;4(4):244-8
references.pmid: 14689372
references.citation: Am J Geriatr Cardiol. 2006 May-Jun;15(3):151-60
references.pmid: 16687967
references.citation: J Clin Hypertens (Greenwich). 2009 Apr;11(4):207-13
references.pmid: 19614805
references.citation: Am J Hypertens. 2004 Apr;17(4):347-53
references.pmid: 15062889
references.citation: Cardiovasc Diabetol. 2007 Oct 02;6:28
references.pmid: 17910747
references.citation: Am J Kidney Dis. 1996 May;27(5):652-63
references.pmid: 8629624
references.citation: N Engl J Med. 1985 Nov 21;313(21):1315-22
references.pmid: 2865677
references.citation: Stroke. 2005 Dec;36(12):2691-5
references.pmid: 16269635
references.citation: Lancet. 2003 Sep 6;362(9386):759-66
references.pmid: 13678868
references.citation: Metabolism. 2006 Sep;55(9):1149-54
references.pmid: 16919531
references.citation: JAMA. 2004 Nov 17;292(19):2350-6
references.pmid: 15547162
references.citation: Am J Hypertens. 2009 Oct;22(10):1126-9
references.pmid: 19730415
references.citation: Lancet. 2002 Mar 23;359(9311):995-1003
references.pmid: 11937178
references.citation: J Int Med Res. 2000 Jul-Aug;28(4):149-67
references.pmid: 11014323
references.citation: Hypertens Res. 2004 Jul;27(7):457-64
references.pmid: 15302981
references.citation: J Hypertens. 2006 Jan;24(1):193-200
references.pmid: 16331118
references.citation: Hypertens Res. 2008 May;31(5):921-9
references.pmid: 18712048
references.citation: J Cardiovasc Pharmacol. 2003 Oct;42(4):491-6
references.pmid: 14508234
references.citation: FEBS Lett. 2004 Oct 22;576(3):492-7
references.pmid: 15498586
references.citation: Blood Press Monit. 2003 Jun;8(3):111-7
references.pmid: 12900588
references.citation: Drug Saf. 2004;27(5):335-44
references.pmid: 15061687
references.citation: Diabetes Care. 2005 Feb;28(2):498
references.pmid: 15677828
references.citation: J Hum Hypertens. 2002 May;16 Suppl 2:S13-6
references.pmid: 11967728
references.citation: N Engl J Med. 2003 Nov 13;349(20):1893-906
references.pmid: 14610160
references.citation: Clin Exp Hypertens. 2005 Aug;27(6):477-89
references.pmid: 16081340
references.citation: N Engl J Med. 2001 Dec 6;345(23):1667-75
references.pmid: 11759645
references.citation: Lancet. 2004 Jun 19;363(9426):2022-31
references.pmid: 15207952
references.citation: Kidney Int. 2000 Aug;58(2):762-9
references.pmid: 10916100
references.citation: Blood Press Monit. 2008 Feb;13(1):21-7
references.pmid: 18199920
references.citation: Hypertension. 2009 Oct;54(4):738-43
references.pmid: 19687349
references.citation: Theor Biol Med Model. 2006 Jan 10;3:1
references.pmid: 16403216
references.citation: Int J Clin Pract Suppl. 2004 Dec;(145):16-22
references.pmid: 15617454
references.citation: Am J Hypertens. 2006 Jan;19(1):104-12
references.pmid: 16461201
references.citation: Diabetes. 2005 Dec;54(12):3442-52
references.pmid: 16306360
references.citation: Curr Pharm Des. 2004;10(14):1695-8
references.pmid: 15134566
references.citation: Lancet. 2002 Dec 14;360(9349):1903-13
references.pmid: 12493255
references.citation: J Hypertens. 2002 May;20(5):865-70
references.pmid: 12011646
references.citation: Endothelium. 2004 Mar-Apr;11(2):133-9
references.pmid: 15370072
references.citation: Hypertension. 2004 May;43(5):993-1002
references.pmid: 15007034
references.citation: J Am Coll Cardiol. 2005 Jun 7;45(11):1832-9
references.pmid: 15936615
references.citation: J Int Med Res. 2005;33 Suppl 1:39A-49A
references.pmid: 16222899
references.citation: Br J Pharmacol. 1993 Sep;110(1):245-52
references.pmid: 8220885
references.citation: Blood Press Monit. 2005 Jun;10(3):157-63
references.pmid: 15923818
references.citation: Hypertens Res. 2005 Jul;28(7):593-600
references.pmid: 16335888
references.citation: Nephrol Dial Transplant. 2008 Oct;23(10):3174-83
references.pmid: 18450829
references.citation: Blood Press Monit. 1998 Oct;3(5):295-302
references.pmid: 10212369
references.citation: Am J Med. 2006 May;119(5 Suppl 1):S3-9
references.pmid: 16563945
references.citation: Biomed Pharmacother. 2003 May-Jun;57(3-4):169-72
references.pmid: 12818479
references.citation: J Hum Hypertens. 2001 Nov;15(11):763-70
references.pmid: 11687919
references.citation: Stroke. 1998 May;29(5):992-6
references.pmid: 9596248
references.citation: J Int Med Res. 2005;33 Suppl 1:21A-29A
references.pmid: 16222897
references.citation: Hypertens Res. 2004 Aug;27(8):545-50
references.pmid: 15492473
references.citation: Int Heart J. 2009 Jul;50(4):501-12
references.pmid: 19609054
references.citation: Drug Metab Dispos. 1999 Oct;27(10):1143-9
references.pmid: 10497140
references.citation: Hypertension. 2001 May;37(5):1236-41
references.pmid: 11358934
references.citation: N Engl J Med. 2008 Apr 10;358(15):1547-59
references.pmid: 18378520
references.citation: J Hum Hypertens. 2005 Dec;19(12):923-31
references.pmid: 16049519
references.citation: Lancet. 2008 Sep 27;372(9644):1174-83
references.pmid: 18757085
references.citation: J Hypertens. 1996 Jan;14(1):47-52
references.pmid: 12013494
references.citation: Cell Mol Biol (Noisy-le-grand). 1998 Nov;44(7):1013-23
references.pmid: 9846883
references.citation: Am J Ther. 1999 May;6(3):161-6
references.pmid: 10423659
references.citation: Blood Press Monit. 2004 Aug;9(4):203-10
references.pmid: 15311147
references.citation: J Renin Angiotensin Aldosterone Syst. 2002 Sep;3(3):176-80
references.pmid: 12563568
references.citation: J Pharmacol Exp Ther. 2001 Jul;298(1):62-70
references.pmid: 11408526
references.citation: Am J Hypertens. 1999 Dec;12(12 Pt 3):189S-194S
references.pmid: 10619571
references.citation: Expert Rev Cardiovasc Ther. 2005 Jul;3(4):691-704
references.pmid: 16076279
references.citation: Clin Ther. 2005 Nov;27(11):1795-805
references.pmid: 16368450
references.citation: Circulation. 2002 Jul 16;106(3):331-6
references.pmid: 12119249
references.citation: Kidney Int. 2008 Aug;74(3):364-9
references.pmid: 18496508
references.citation: J Hypertens. 2005 May;23(5):1061-6
references.pmid: 15834293
references.citation: Int J Clin Pract Suppl. 2004 Dec;(145):50-4
references.pmid: 15617460
references.citation: Clin Ther. 2001 Jan;23(1):108-23
references.pmid: 11219471
references.citation: Curr Ther Res Clin Exp. 2008 Feb;69(1):1-15
references.pmid: 24692778
references.citation: Am Heart J. 2006 Jan;151(1):176-84
references.pmid: 16368314
references.citation: Clin Ther. 2001 Jun;23(6):833-50
references.pmid: 11440284
references.citation: Blood Press Monit. 2002 Apr;7(2):111-6
references.pmid: 12048428
references.citation: J Hypertens. 2006 Sep;24(9):1809-16
references.pmid: 16915030
references.citation: Int J Clin Pract Suppl. 2004 Dec;(145):35-9
references.pmid: 15617457
references.citation: Atherosclerosis. 2006 Jun;186(2):402-10
references.pmid: 16157344
references.citation: Hypertension. 2005 Jul;46(1):137-43
references.pmid: 15939809
references.citation: Int J Clin Pharmacol Res. 2005;25(1):41-6
references.pmid: 15864875
references.citation: Lancet. 1978 Apr 15;1(8068):795-7
references.pmid: 85815
references.citation: Int J Cardiol. 2001 Feb;77(2-3):131-8; discussion 139-40
references.pmid: 11182175
references.citation: J Hypertens. 1986 Oct;4(5):543-50
references.pmid: 3540117
references.citation: Cardiovasc Diabetol. 2005 May 15;4:6
references.pmid: 15892894
references.citation: J Hypertens. 2004 May;22(5):1033-7
references.pmid: 15097245
references.citation: Cardiovasc Res. 2002 Feb 1;53(2):304-12
references.pmid: 11827680
references.citation: Hypertens Res. 2008 Jan;31(1):7-13
references.pmid: 18360012
references.citation: Clin Ther. 2004 Aug;26(8):1228-36
references.pmid: 15476904
references.citation: Microvasc Res. 2005 Nov;70(3):137-41
references.pmid: 16271939